Baird lowered the firm’s price target on Xponential Fitness (XPOF) to $13 from $15 and keeps a Neutral rating on the shares. The firm said Q3 revenue beat, while adjusted EBITDA fell short on lower margin performance.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks